Eidolon Therapeutics is pioneering a novel form of immunotherapy that reshapes tumour immunity and eliminates cancer cells using engineered immune regulators derived from microbial proteins.
Company Details
- Founded
- -
- Address
- 237 Fulham Road, London, London,sw3 6jb,united Kingdom
- Industry
- Hospitals And Health Care
- NAICS
-
Health Care and Social AssistanceSocial Assistance
- HQ
- London
Eidolon Therapeutics Questions
Eidolon Therapeutics's website is http://www.eidolontherapeutics.com
Eidolon Therapeutics's LinkedIn profile is https://uk.linkedin.com/company/eidolontherapeutics
Eidolon Therapeutics's industry is
Hospitals and Health Care
Eidolon Therapeutics's top competitors are
Amply Discovery,
Twin Path Ventures,
Sekhmet Biomed,
Korean Uk Life Sciences Association (Kulsa),
Lume,
Alzheimer's Disease International,
Trinity Life Sciences,
Zs,
Irb Barcelona,
Evotouch.
Eidolon Therapeutics's categories are Hospitals and Health Care
Eidolon Therapeutics's founding year is 2025
